AR003973A1 - Forma cristalina biodisponible de axetil cefuroxima y proceso para producirla - Google Patents
Forma cristalina biodisponible de axetil cefuroxima y proceso para producirlaInfo
- Publication number
- AR003973A1 AR003973A1 ARP960103834A AR10383496A AR003973A1 AR 003973 A1 AR003973 A1 AR 003973A1 AR P960103834 A ARP960103834 A AR P960103834A AR 10383496 A AR10383496 A AR 10383496A AR 003973 A1 AR003973 A1 AR 003973A1
- Authority
- AR
- Argentina
- Prior art keywords
- bio
- crystalline form
- produce
- available crystalline
- cefuroxime
- Prior art date
Links
- 229950003588 axetil Drugs 0.000 title 1
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 title 1
- 229960001668 cefuroxime Drugs 0.000 title 1
- KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 abstract 2
- 229960002620 cefuroxime axetil Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Una forma cristalina biodisponible de axetil cefuroxima que se obtiene tratando una forma conocida cristalina o amorfa de axetil cefuroxima con agua oun disolvente orgánico miscible en agua o con una mezcla de los mismos bajo una temperaturaque oscila entre +20°C y +100°C, luego de lo cual se procede alenfriamiento y separación del producto cristalino a través de métodos conocidos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001716A IT1277426B1 (it) | 1995-08-03 | 1995-08-03 | Forma cristallina biodisponibile del cefuroxima axetil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR003973A1 true AR003973A1 (es) | 1998-09-30 |
Family
ID=11372130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960103834A AR003973A1 (es) | 1995-08-03 | 1996-08-01 | Forma cristalina biodisponible de axetil cefuroxima y proceso para producirla |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5677443A (es) |
| EP (1) | EP0757991B1 (es) |
| JP (1) | JPH09104685A (es) |
| KR (1) | KR970010776A (es) |
| CN (1) | CN1055693C (es) |
| AR (1) | AR003973A1 (es) |
| AT (1) | ATE195126T1 (es) |
| BR (1) | BR9603270A (es) |
| CA (1) | CA2179359A1 (es) |
| DE (1) | DE69609576T2 (es) |
| DK (1) | DK0757991T3 (es) |
| ES (1) | ES2150052T3 (es) |
| FI (1) | FI962937A7 (es) |
| GR (1) | GR3034663T3 (es) |
| IL (1) | IL118822A (es) |
| IT (1) | IT1277426B1 (es) |
| MX (1) | MX9603110A (es) |
| PT (1) | PT757991E (es) |
| RU (1) | RU2155767C2 (es) |
| SI (1) | SI0757991T1 (es) |
| TR (1) | TR199600691A2 (es) |
| TW (1) | TW413635B (es) |
| UA (1) | UA46727C2 (es) |
| ZA (1) | ZA965234B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2725382B1 (fr) * | 1994-10-05 | 1997-01-03 | Commissariat Energie Atomique | Polyazacycloalcanes, complexes tri-, tetra- ou pentaazamacrocycliques, procede de fabrication de ces polyazacycloalcanes substitues ou non et greffes sur un support et utilisations des polyazacycloalcanes |
| NZ299077A (en) * | 1996-07-26 | 1998-06-26 | Apotex Inc | Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf |
| KR100401284B1 (ko) * | 1997-06-03 | 2004-01-31 | 주식회사유한양행 | 1-브로모에틸 아세테이트의 제조방법 |
| CA2209868C (en) * | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
| IN186539B (es) * | 1997-09-29 | 2001-09-29 | Ranbaxy Lab Ltd | |
| ES2171056T3 (es) * | 1998-02-20 | 2002-08-16 | Fako Ilaclari A S | Procedimiento para la fabricacion de cefuroxima axetil cristalina soluble. |
| US6384213B1 (en) | 1998-10-23 | 2002-05-07 | Ranbaxy Laboratories Limited | Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil |
| IN190849B (es) * | 2000-07-17 | 2003-08-23 | Ranbaxy Lab Ltd | |
| ITMI20011763A1 (it) * | 2001-08-10 | 2003-02-10 | Antibioticos Spa | Processo di preparazione di cefuroxime axelite ad elevata purezza |
| ITMI20011925A1 (it) * | 2001-09-14 | 2003-03-14 | Antibioticos Spa | Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino |
| ES2201932B2 (es) * | 2001-11-23 | 2005-03-16 | Glaxo Group Limited | Composicion farmaceutica. |
| CN1909889B (zh) * | 2004-01-09 | 2010-06-02 | 韩美药品株式会社 | 头孢呋辛酯颗粒及其制备方法 |
| CN100448879C (zh) * | 2004-07-22 | 2009-01-07 | 北京化工大学 | 一种无定型头孢呋辛酯的制备方法 |
| DE102005019458A1 (de) * | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil |
| WO2007063552A1 (en) * | 2005-12-02 | 2007-06-07 | Lupin Limited | Stable taste masked formulations of cephalosporins |
| DE102006019619A1 (de) * | 2006-04-25 | 2007-10-31 | Grünenthal GmbH | Kristalline Modifikation von Cefuroximaxetil |
| CN102417451B (zh) * | 2011-12-20 | 2013-12-04 | 浙江国邦药业有限公司 | 一种合成(r,s)1-溴代乙基乙酸酯的制备方法 |
| WO2014040239A1 (zh) * | 2012-09-12 | 2014-03-20 | 海南卫康制药(潜山)有限公司 | 头孢呋辛钠晶型化合物及其组合物粉针 |
| CN106554361B (zh) * | 2016-09-30 | 2018-10-09 | 华北制药河北华民药业有限责任公司 | 一种头孢呋辛酯口服制剂的制备方法 |
| CN115594583A (zh) * | 2022-10-13 | 2023-01-13 | 浙江东盈药业有限公司(Cn) | 一种1-溴乙基乙酸酯的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1094545A (en) * | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
| GB1571683A (en) * | 1976-02-16 | 1980-07-16 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| GB8320521D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
| US5063224A (en) * | 1990-07-09 | 1991-11-05 | Eli Lilly And Company | R-cefuroxime axetil |
-
1995
- 1995-08-03 IT IT95MI001716A patent/IT1277426B1/it active IP Right Grant
-
1996
- 1996-06-17 AT AT96109665T patent/ATE195126T1/de not_active IP Right Cessation
- 1996-06-17 SI SI9630229T patent/SI0757991T1/xx unknown
- 1996-06-17 DE DE69609576T patent/DE69609576T2/de not_active Expired - Fee Related
- 1996-06-17 US US08/664,552 patent/US5677443A/en not_active Expired - Fee Related
- 1996-06-17 ES ES96109665T patent/ES2150052T3/es not_active Expired - Lifetime
- 1996-06-17 EP EP96109665A patent/EP0757991B1/en not_active Expired - Lifetime
- 1996-06-17 PT PT96109665T patent/PT757991E/pt unknown
- 1996-06-17 DK DK96109665T patent/DK0757991T3/da active
- 1996-06-18 CA CA002179359A patent/CA2179359A1/en not_active Abandoned
- 1996-06-20 ZA ZA965234A patent/ZA965234B/xx unknown
- 1996-06-25 TW TW085107604A patent/TW413635B/zh not_active IP Right Cessation
- 1996-07-09 IL IL11882296A patent/IL118822A/xx not_active IP Right Cessation
- 1996-07-23 FI FI962937A patent/FI962937A7/fi unknown
- 1996-07-30 KR KR1019960031374A patent/KR970010776A/ko not_active Ceased
- 1996-07-31 MX MX9603110A patent/MX9603110A/es unknown
- 1996-08-01 AR ARP960103834A patent/AR003973A1/es unknown
- 1996-08-01 CN CN96109271A patent/CN1055693C/zh not_active Expired - Fee Related
- 1996-08-02 BR BR9603270A patent/BR9603270A/pt not_active Application Discontinuation
- 1996-08-02 UA UA96083116A patent/UA46727C2/uk unknown
- 1996-08-02 JP JP8205098A patent/JPH09104685A/ja active Pending
- 1996-08-02 RU RU96115329/04A patent/RU2155767C2/ru active
- 1996-08-28 TR TR96/00691A patent/TR199600691A2/xx unknown
-
2000
- 2000-10-23 GR GR20000402353T patent/GR3034663T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199600691A3 (tr) | 1998-03-21 |
| ES2150052T3 (es) | 2000-11-16 |
| EP0757991B1 (en) | 2000-08-02 |
| FI962937L (fi) | 1997-02-04 |
| CA2179359A1 (en) | 1997-02-04 |
| AU6083396A (en) | 1997-02-06 |
| IL118822A (en) | 1999-11-30 |
| IT1277426B1 (it) | 1997-11-10 |
| US5677443A (en) | 1997-10-14 |
| PT757991E (pt) | 2000-11-30 |
| ATE195126T1 (de) | 2000-08-15 |
| DK0757991T3 (da) | 2000-09-04 |
| DE69609576T2 (de) | 2001-01-04 |
| EP0757991A1 (en) | 1997-02-12 |
| IL118822A0 (en) | 1996-10-31 |
| JPH09104685A (ja) | 1997-04-22 |
| ZA965234B (en) | 1997-03-06 |
| KR970010776A (ko) | 1997-03-27 |
| FI962937A7 (fi) | 1997-02-04 |
| ITMI951716A1 (it) | 1997-02-03 |
| TW413635B (en) | 2000-12-01 |
| TR199600691A2 (xx) | 1998-03-21 |
| ITMI951716A0 (it) | 1995-08-03 |
| DE69609576D1 (de) | 2000-09-07 |
| CN1055693C (zh) | 2000-08-23 |
| RU2155767C2 (ru) | 2000-09-10 |
| AU700214B2 (en) | 1998-12-24 |
| BR9603270A (pt) | 1998-04-28 |
| GR3034663T3 (en) | 2001-01-31 |
| UA46727C2 (uk) | 2002-06-17 |
| SI0757991T1 (en) | 2000-12-31 |
| MX9603110A (es) | 1997-06-28 |
| CN1147516A (zh) | 1997-04-16 |
| FI962937A0 (fi) | 1996-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003973A1 (es) | Forma cristalina biodisponible de axetil cefuroxima y proceso para producirla | |
| MX9203962A (es) | Proceso para acondicionamiento de pigmentos organicos. | |
| IT962125B (it) | Composti silicio organici solforati e procedimento per la loro produ zione | |
| ES2126355T3 (es) | Procedimiento para la preparacion de creatina o monohidrato de creatina. | |
| SE7611047L (sv) | Forfarande for framstellning av antibakteriella emnen | |
| SE8403897L (sv) | Cefalosporiner | |
| CA958037A (en) | Thermal decomposition of organic compounds | |
| AR046229A1 (es) | Procesos para la preparacion de cefalosporina 3-(2-vinilo sustituido) altamente pura | |
| BE799963A (fr) | Procede de preparation de poly-(halogenures de vinyle), | |
| IT1009333B (it) | Procedimento per la produzione di un fertilizzante biologico utiliz zando acque di scarico o scoli di fognature | |
| JPS5218489A (en) | Process for production of carbon material | |
| ES8600322A1 (es) | Un procedimiento para obtener compuestos de 2'-o-acil-, 3'-o-acil-, 2',3'-di-o-acil- y 2',3',5'-tri-o-acil-2-b-d-ribofuranosilselenazol-4-carboxamida | |
| FR2362856A1 (fr) | 7-(2-(benzoyl substitue) amino) acetamido) cephalosporines actives contre les microorganismes de l'espece pseudomonas | |
| GB1470329A (en) | Antibiotic derivatives of xk-62-2 and method of production thereof | |
| CA993879A (en) | Process for the decomposition of organic peroxy compounds | |
| SU1805636A1 (ru) | Способ получения гидроксида алюминия | |
| BE758035A (fr) | Procede de couplage par reduction de composes organiques halogenes | |
| ES2165376T3 (es) | Procedimiento de moldeado de polipropileno sindiotactico. | |
| SE7612960L (sv) | Tienamycinderivat | |
| JPS6446A (en) | Production of 4-hydroxy-2-cyclopentenone derivative | |
| TH28669B (th) | รูปผลึกที่ใช้ได้ในทางชีววิทยาของเซฟฟูรอกซีมแอกซีติล | |
| SU462818A1 (ru) | Способ получени производных 2,3диамино-1,4-дифторантрахинона | |
| JPS5221176A (en) | Box for driving away harmful birds | |
| PT91383A (pt) | Processo para a preparacao do acido (5r,6s)-2-carbamoiloximetil-6-{(1r)-hidroxi-etil}-2-penem-3-carboxilico sob a forma cristalina e de composicoes farmaceuticas que o contem | |
| RU95109671A (ru) | Способ получения кристаллической безводной формы сульфоксида бензилпенициллина |